127 related articles for article (PubMed ID: 29764574)
1. [Clinical effect and mechanism of hemoperfusion in treatment of children with severe abdominal Henoch-Schönlein purpura].
Zhu Y; Dong Y; Xu DL; Jiang JY; Wu L; Ke RJ; Fang SH; Peng Y
Zhongguo Dang Dai Er Ke Za Zhi; 2018 May; 20(5):378-382. PubMed ID: 29764574
[TBL] [Abstract][Full Text] [Related]
2. Changes of inflammatory mediators and oxidative stress indicators in children with Henoch-Schönlein purpura and clinical effects of hemoperfusion in the treatment of severe Henoch-Schönlein purpura with gastrointestinal involvement in children.
Zhu Y; Dong Y; Wu L; Deng F
BMC Pediatr; 2019 Nov; 19(1):409. PubMed ID: 31684904
[TBL] [Abstract][Full Text] [Related]
3. Analysis on kidney injury-related clinical risk factors and evaluation on the therapeutic effects of hemoperfusion in children with Henoch-Schonlein purpura.
Ma DQ; Li Y; Han ZG; Zheng M; Xu N; Fan XJ
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3894-3899. PubMed ID: 28975974
[TBL] [Abstract][Full Text] [Related]
4. Effects of hemoperfusion in the treatment of childhood Henoch-Schönlein purpura nephritis.
Chen L; Wang Z; Zhai S; Zhang H; Lu J; Chen X
Int J Artif Organs; 2013 Jul; 36(7):489-97. PubMed ID: 23661557
[TBL] [Abstract][Full Text] [Related]
5. [Effects of hemoperfusion treatment on serum IL-23 and IL-17 levels in children with Henoch-Schönlein purpure].
Liu L; Huang YP; Fang XL; Zhang YY; Chen N; Hou HH
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Aug; 17(8):796-9. PubMed ID: 26287341
[TBL] [Abstract][Full Text] [Related]
6. Erythrocyte superoxide dismutase activity and plasma malondialdehyde levels in children with Henoch Schönlein purpura.
Demircin G; Oner A; Unver Y; Bülbül M; Erdoğan O
Acta Paediatr; 1998 Aug; 87(8):848-52. PubMed ID: 9736232
[TBL] [Abstract][Full Text] [Related]
7. [Clinical Significance of Serum Midkine in Children with Henoch-Schonlein Purpura].
Li MM; Liu N; Zhagn M; Xue HR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):181-185. PubMed ID: 28245398
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic analysis of children with Henoch-Schonlein purpura treated by Helicobacter pylori eradication therapy].
Cai HB; Li YB; Zhao H; Zhou SM; Zhao XD
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Mar; 16(3):234-7. PubMed ID: 24661512
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum heme oxygenase-1 and insulin-like growth factor-1 levels in patients with Henoch-Schonlein purpura.
Chen T; Guo ZP; Zhang YH; Gao Y; Liu HJ; Li JY
Rheumatol Int; 2011 Mar; 31(3):321-6. PubMed ID: 20013271
[TBL] [Abstract][Full Text] [Related]
10. [Roles of serum and urinary interleukins 13Ralpha2 and other cytokines in pediatric Henoch-Schonlein purpura].
Yu YH; Pan KL; Li Q; Zhang BJ; Huang Y; Zhang JJ; DU L
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan; 11(1):37-40. PubMed ID: 19149920
[TBL] [Abstract][Full Text] [Related]
11. Cytokine pattern and endothelium damage markers in Henoch-Schönlein purpura.
Del Vecchio GC; Penza R; Altomare M; Piacente L; Aceto G; Lassandro G; De Mattia D; Giordano P
Immunopharmacol Immunotoxicol; 2008; 30(3):623-9. PubMed ID: 18668398
[TBL] [Abstract][Full Text] [Related]
12. [Effect of danshao granule on serum superoxide dismutase activity and malonyldialdehyde content in children with Henoch-Schonlein purpura nephritis].
Jin ZD; Wang SC; Sun YQ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Dec; 23(12):905-7. PubMed ID: 14714360
[TBL] [Abstract][Full Text] [Related]
13. [Role of Imbalance between Th17 Cells and Treg Cells in the Pathogenesis of Children with Henoch-Schonlein Purpura].
Wang Q; Shi YY; Cao M; Dong W; Zhang JB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1391-6. PubMed ID: 26524044
[TBL] [Abstract][Full Text] [Related]
14. [Clinical effect of alanyl-glutamine-enriched nutritional support in the treatment of children with abdominal Henoch-Schönlein purpura].
Xiong LJ; Shang LH; Ou XQ; Li Y; Xie XL
Zhongguo Dang Dai Er Ke Za Zhi; 2019 Feb; 21(2):168-171. PubMed ID: 30782281
[TBL] [Abstract][Full Text] [Related]
15. Add-on therapy with montelukast in the treatment of Henoch-Schönlein purpura.
Wu SH; Liao PY; Chen XQ; Yin PL; Dong L
Pediatr Int; 2014 Jun; 56(3):315-22. PubMed ID: 24299021
[TBL] [Abstract][Full Text] [Related]
16. Clinical effect of alfacalcidol in children with Henoch-Schönlein purpura: a prospective randomized controlled trial.
Fu Q; Shi MF; Chen Y
Zhongguo Dang Dai Er Ke Za Zhi; 2021 Aug; 23(8):797-801. PubMed ID: 34511168
[TBL] [Abstract][Full Text] [Related]
17. Effect of vitamin E treatment on the oxidative damage occurring in Henoch-Schönlein purpura.
Erdoğan O; Oner A; Aydin A; Işimer A; Demircin G; Bülbül M
Acta Paediatr; 2003 May; 92(5):546-50. PubMed ID: 12839282
[TBL] [Abstract][Full Text] [Related]
18. Hemoperfusion and intravenous immunoglobulins for refractory gastrointestinal involvement in pediatric Henoch-Schönlein purpura: a single-center retrospective cohort study.
Zhang X; Che R; Xu H; Ding G; Zhao F; Huang S; Zhang A
BMC Pediatr; 2022 Dec; 22(1):692. PubMed ID: 36460986
[TBL] [Abstract][Full Text] [Related]
19. [Association of tumor necrosis factor-alpha gene polymorphisms with Henoch-Schonlein purpura nephritis in children].
Wang JJ; Shi YP; Huang Y; Wu C; Li XC
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Feb; 15(2):88-90. PubMed ID: 23428118
[TBL] [Abstract][Full Text] [Related]
20. The role of tumor necrosis factor-alpha in Henoch-Schonlein purpura.
Ha TS
Pediatr Nephrol; 2005 Feb; 20(2):149-53. PubMed ID: 15627167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
